These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38188831)

  • 1. Retracted: Demographics and Economic Burden of Nasopharyngeal Carcinoma Inpatients.
    International BR
    Biomed Res Int; 2023; 2023():9850320. PubMed ID: 38188831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics and Economic Burden of Nasopharyngeal Carcinoma Inpatients.
    Yang D; Bin N; Zhou Z; Li Z; Shen M; Yang C; Qin Y; Wang R; Lv W; Wei B; Zhou L; Kang M
    Biomed Res Int; 2022; 2022():6958806. PubMed ID: 35757475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9781420. PubMed ID: 37416142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1.
    International SC
    Stem Cells Int; 2024; 2024():9763687. PubMed ID: 38298234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9836790. PubMed ID: 38074350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Application of Artificial Intelligence in Radiotherapy of Nasopharyngeal Carcinoma with Magnetic Resonance Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9825710. PubMed ID: 38094840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9829630. PubMed ID: 37946834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9856726. PubMed ID: 37475936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9812746. PubMed ID: 37387977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] miR‑639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma.
    Wang YH; Yin YW; Zhou H; Cao YD
    Oncol Lett; 2024 Feb; 27(2):76. PubMed ID: 38192678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9809608. PubMed ID: 37547642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9798503. PubMed ID: 37416222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Relationship between miR-338-3p and Clinicopathological Parameters, Prognosis, and STAT3 mRNA Expression in Nasopharyngeal Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9843805. PubMed ID: 37388095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9804984. PubMed ID: 37416199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Analysis of the Molecular Mechanism of
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864290. PubMed ID: 37476805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor.
    Zhu W; Ma Y; Zhuang X; Jin X
    Oncol Lett; 2024 Mar; 27(3):112. PubMed ID: 38304176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: S100A8/A9 Molecular Complexes Promote Cancer Migration and Invasion via the p38 MAPK Pathway in Nasopharyngeal Carcinoma.
    And Applications BC
    Bioinorg Chem Appl; 2023; 2023():9859513. PubMed ID: 38093950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma.
    And Applications BC
    Bioinorg Chem Appl; 2023; 2023():9895467. PubMed ID: 38093937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Effects of Self-Care plus Forecasting Nursing on the Treatment Outcomes and Emotions in Patients with Nasopharyngeal Carcinoma after Radiotherapy.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9847364. PubMed ID: 38093884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors.
    Neuroscience CIA
    Comput Intell Neurosci; 2022; 2022():9854614. PubMed ID: 36601276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.